Sana Biotechnology, Inc. cotiza a 2.41 USD y tiene una capitalización bursátil de $721M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. T…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.13 | $-0.14 | $-0.16 |
| Estimado | $-0.10 | $-0.12 | $-0.15 | $-0.13 |
| Sorpresa | — | -8.3% | +6.7% | -23.1% |
| Métrica | SANA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -151.8% | -40.4% | -111.4% |
| ROA | -58.6% | -32.0% | -26.6% |
| Current Ratio | 1.89 | 2.84 | -0.95 |
| Debt / Equity | — | 0.28 | — |